Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5594575 | American Heart Journal | 2017 | 31 Pages |
Abstract
Despite the high baseline CV risk among patients in the NAVIGATOR trial, the most common cause of death was non-CV. The high burden of non-CV death in this population has potential implications for future CV event-driven trials.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Abhinav MD, Flávio MD, Jie-Lena MSc, Laine PhD, Steven MD, Rury R. FRCP, FMedSci, Renato D. MD, PhD, MHS,